BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29513749)

  • 1. Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells.
    Monma H; Iida Y; Moritani T; Okimoto T; Tanino R; Tajima Y; Harada M
    PLoS One; 2018; 13(3):e0193990. PubMed ID: 29513749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
    Hari Y; Harashima N; Tajima Y; Harada M
    Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL.
    Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH
    Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer.
    Monma H; Harashima N; Inao T; Okano S; Tajima Y; Harada M
    Mol Cancer Ther; 2013 Apr; 12(4):341-51. PubMed ID: 23371857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo.
    Qiao X; Wang X; Shang Y; Li Y; Chen SZ
    Cancer Commun (Lond); 2018 Jul; 38(1):43. PubMed ID: 29970185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine reverses chemoresistance via upregulation of p21
    Hwang JR; Kim WY; Cho YJ; Ryu JY; Choi JJ; Jeong SY; Kim MS; Kim JH; Paik ES; Lee YY; Han HD; Lee JW
    Cell Death Dis; 2020 Dec; 11(12):1034. PubMed ID: 33277461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy facilitates the development of resistance to the tumor necrosis factor superfamily member TRAIL in breast cancer.
    Lv S; Wang X; Zhang N; Sun M; Qi W; Li Y; Yang Q
    Int J Oncol; 2015 Mar; 46(3):1286-94. PubMed ID: 25572822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
    Lv X; Liu F; Shang Y; Chen SZ
    Oncol Rep; 2015 Sep; 34(3):1289-300. PubMed ID: 26136140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells.
    Khanbolooki S; Nawrocki ST; Arumugam T; Andtbacka R; Pino MS; Kurzrock R; Logsdon CD; Abbruzzese JL; McConkey DJ
    Mol Cancer Ther; 2006 Sep; 5(9):2251-60. PubMed ID: 16985059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
    Zhu K; Fang W; Chen Y; Lin S; Chen X
    Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitizing TRAIL‑resistant A549 lung cancer cells and enhancing TRAIL‑induced apoptosis with the antidepressant amitriptyline.
    Zinnah KMA; Park SY
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells.
    Park EJ; Min KJ; Choi KS; Kubatka P; Kruzliak P; Kim DE; Kwon TK
    Sci Rep; 2016 Mar; 6():22921. PubMed ID: 26964637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N,N'-di-(m-methylphenyi)-3,6-dimethyl-1,4-dihydro-1,2,4,5-tetrazine-1,4-dicarboamide (ZGDHu-1) suppresses the proliferation of PANC-1 pancreatic cancer cells via apoptosis and G2/M cell cycle arrest.
    Chen SF; Xia J; Lv YP; Liu JL; Li WX; Yu XP; Hu WX; Zhou YL
    Oncol Rep; 2015 Apr; 33(4):1915-21. PubMed ID: 25683065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
    Dai H; Jiang Y; Luo Y; Bie P; Chen Z
    Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells.
    Tanaka R; Tomosugi M; Horinaka M; Sowa Y; Sakai T
    PLoS One; 2015; 10(5):e0125779. PubMed ID: 25955843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of XAF1 expression induces apoptosis and inhibits tumor growth in gastric cancer.
    Tu SP; Liston P; Cui JT; Lin MC; Jiang XH; Yang Y; Gu Q; Jiang SH; Lum CT; Kung HF; Korneluk RG; Wong BC
    Int J Cancer; 2009 Aug; 125(3):688-97. PubMed ID: 19358264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition.
    Fukuda T; Oda K; Wada-Hiraike O; Sone K; Inaba K; Ikeda Y; Miyasaka A; Kashiyama T; Tanikawa M; Arimoto T; Kuramoto H; Yano T; Kawana K; Osuga Y; Fujii T
    Gynecol Oncol; 2015 Jun; 137(3):538-45. PubMed ID: 25842161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.